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Abstract.  Axonin-I  is a  glycoprotein that is released 
from axons of cultured neurons (Stoecldi, E.  T.,  E  E 
Lemkin,  T. B.  Kuhn,  M.  A.  Ruegg, M.  Heller, and E 
Sonderegger.  1989.  Fur.  J.  Biochem.  180:249-258).  It 
has recently been purified from the ocular vitreous 
fluid of the chicken embryo (Ruegg, M.  A.,  E.  T. 
Stoeckli, T.  B.  Kuhn,  M.  I-Idler,  R. Zuellig, and E 
Sonderegger.  1989.  EMBO (Fur. Mol.  Biol.  Organ.) J. 
8:55-63).  Immunohistochemistry localized axonin-1 
prevalently in developing nerve fiber tracts.  The pres- 
ence of anti-axonin-1  Fab fragments during axon 
growth in vitro resulted in antibody binding to the ax- 
onal surfaces and in a  marked perturbation of the fas- 
ciculation pattern.  Hence, a  fraction of axonin-1  is as- 
sociated with axonal membranes and,  by operational 
criteria,  qualifies as a cell adhesion molecule.  The 
major proportion of membrane-associated axonin-1  co- 
solubilized with the integral  membrane proteins.  By 
physico-chemical, immunological,  and protein- 
chemical criteria,  the integral membrane form was 
found to be highly similar to soluble axonin-1.  In com- 
mon with a number of other cell adhesion molecules, 
both soluble and membrane-bound axonin-1  express 
the L2/HNK-1 and the L3 epitopes.  Radioactive 
pulse-chase and double-labeling experiments revealed 
that the released form was not derived from the 
membrane-bound form by shedding from the mem- 
brane surface, but directly secreted from an intracellu- 
lar pool. Due to its high degree of similarity to the 
membrane-associated form and the presence of the 
L2/HNK-1 and L3 epitopes, reported to be ligands in 
adhesive cell interactions,  adhesive properties are 
postulated for secreted axonin-1.  As a soluble adhesive 
protein,  it may function as a regulator of cell adhesion 
around its most likely site of secretion, the growth 
cone. 
URING neural  development, a  variety of interactive 
processes between axons and their  cellular and ex- 
tracellular matrix  (ECM) ~ environments  have been 
observed. Over the past decade, cell surface exposed glyco- 
proteins with adhesive properties to other cells or the ECM 
have become established as one of the dominant  molecular 
factors  promoting the elongation  of axons and/or directing 
them to the target area (for a recent review cf. Rutishauser 
and Jessel, 1988). Proteins secreted from axons during this 
developmental  period have been implicated  in a number of 
tasks  subserving these goals.  Secreted proteases were sug- 
gested to evoke a local  weakening  of adhesive  cell-cell or 
celI-ECM interactions  resulting in a terrain favorable for the 
intercalation  of the advancing  growth  cone (Krystosek and 
Seeds, 1981, 1984). A secretory contribution of axons to the 
local construction or reconstruction of the ECM at the site 
1. Abbreviations  used in this paper:  Ax-CAM, axon-associated  adhesion 
molecule;  CHAPS,  3-(3-cholamidopropyl)dimethyl-ammonio-l-propane 
sulfonate;  DRG,  dorsal root ganglia; ECM,  extracellular matrix; NILE, 
nerve growth factor-inducible large external glycoprotein;  PIB, protease in- 
hibitor buffer. 
of the developing  synapse was implied  by the observation 
that the specialized  synaptic ECM induced the formation of 
postsynaptic  specializations  in the absence of a presynaptic 
nerve ending (Burden et al., 1979). Such observations have 
entailed a number of studies aiming to identify and purify the 
underlying soluble or extracellularly  deposited macromole- 
cules.  McMahan and collaborators engaged in the purifica- 
tion of a synaptogenic agent found in extracts of the synaptic 
basal lamina of the Torpedo electric organ.  On the basis of 
its capability to induce the aggregation of acetylcholine recep- 
tors on cultured myotubes, they isolated a 95/150-kD doublet 
glycoprotein, which they called agrin (Godfrey et al., 1984; 
Nitkin  et al.,  1987).  Recent findings  suggest  that,  in the 
chick nervous system, agrin-like molecules are secreted from 
motor neurons  (Magill-Solc  and McMahan,  1988).  Kelly 
and collaborators identified a proteoglycan of synaptic vesi- 
cles that is externalized  and deposited in the synaptic cleft; 
because of its proposed function, it was termed "terminal an- 
chorage protein" or TAP-1 (Caroni  et al.,  1985; Carlson et 
al., 1986). Pittman (1985) used an ingenious protease detec- 
tion technique  for the identification  and characterization  of 
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and found a plasminogen activator and a calcium-dependent 
metalloprotease among the proteins released from axons of 
cultured neurons. 
In our laboratory, we have chosen the compartmentalized 
cell  culture  system devised by Campenot  (1977) for the 
identification of axonally secreted  proteins.  Two  proteins 
released from axons of embryonic chicken dorsal root gan- 
glion neurons in culture were  identified (Stoeckli et al., 
1989).  One of them, termed axonin-1,  was detected in the 
vitreous humor of the eye and subsequently purified (Ruegg 
et al.,  1989).  Axonin-1  was found to be predominantly ex- 
pressed during the second half of embryonic life, concentra- 
tions in the adult being ,020 times lower. To determine the 
functional role of axonin-1, its expression in the embryonic 
nervous system was studied by immunohistochemical tech- 
niques, and perturbation studies with antibodies were car- 
ried out on axons extending from cultured dorsal root gan- 
glia.  The  data reported  here  identify and characterize  a 
membrane-bound homologue of axonin-1  and demonstrate 
its prevalence in nerve fiber tracts. Fab fragments of anti- 
axonin-1 antibodies added to growing axons bind to the ax- 
onal surface and interfere with the formation of axon fasci- 
cles. Based on these observations,  the membrane-bound form 
of axonin-1 operationally qualifies as a cell adhesion mole- 
cule. The high degree of structural similarity with membrane- 
bound axonin-1 and the observation that it has structural fea- 
tures in common with established cell adhesion molecules 
suggests that secreted axonin-1 could have adhesive proper- 
ties. Hence, it could represent a regulatory element in cell 
adhesion during neurogenesis. 
Materials and Methods 
Antibodies and Fab Fragments 
Antibodies against axonin-1 were raised in rabbit and goat as previously de- 
scribed (Ruegg et al., 1989). IgG of rabbit immune or nonimmune sera were 
precipitated  with 40% ammonium sulfate at 4°C and further purified by an- 
ion exchange chromatography  (Fast Flow Q; Pharmacia Fine Chemicals, 
Uppsaia,  Sweden).  The purity of the isolated  fractions were checked by 
SDS-PAGE. Fab fragments were produced by mercuripapain digestion ac- 
cording to Porter (1959).  lab fragments were isolated by cation exchange 
chromatography  (mono S; Pharmacia Fine Chemicals). FOr antibody per- 
turbation experiments,  Fab fragments  were concentrated by ultrafiitration 
(diaflo, PM-30; Amicon Corporation, Danvers,  MA) and dialyzed  against 
Dulbecco's  PBS. 
lmmunohistochemistry 
For indirect immunofluorescence localization of axonin-l,  12-vm-thick frozen 
sections were cut from 5.5-d embr~nic spinal cord and 8-d retina (stage 
28 and stage 34, respectively;  Hamburger and Hamilton, 1951), fixed in a 
mixture of 2% paraforrnaidehyde  and 0.1% glutaraldehyde  in 0.1 M sodium 
phosphate,  pH 7.4. Goat antiserum against axonin-I was added at a dilution 
of 1:1,000 and incubated for 14 h at 4°C.  As a second antibody,  FITC- 
conjugated  rabbit anti-goat IgG (Zymed Laboratories Inc., San Francisco, 
CA) was added at a dilution of 1:20 and incubated for 90 rain at 21°C. After 
staining, the sections were coverslipped  with 90% glycerol,  10% PBS, pH 
8.0, containing 1 my,/ml phenylenediamine, and examined with a fluores- 
cence microscope (Wild and Leitz AG, Zurich, Switzerland)  using the L2 
band pass filter set for FITC. 
Cell Cultures 
Dissociated  cells from dorsal root ganglia of 10-d chicken embryos were 
cultivated on collagen-coated  tissue culture dishes (35 mm in diameter) as 
previously  described  (Sonderegger  et al.,  1984).  Proliferation of non- 
neuronal cells was minimized by the inclusion of 0.12 mM 5-fluorodeoxy- 
uridine and 0.3 m.M uridine (both from Sigma Chemical Co., St.  Louis, 
MO). For pulse-labeling and pulse-chase experiments, a density of 350,000- 
400,000 cells per dish was found to be roost suitable. 
For antibody-induced  perturbation of neurite fasciculntion,  dorsal root 
ganglia were explanted into small droplets of medium containing immune 
or  nonimmune Fab  fragments at  a  concentration of  100  pg/mi  on  a 
polylysine-coated  culture dish. After 1 d, when the ganglia bad attached, 
1 ml of culture medium containing immune or nonimmune Fab fragments 
was added.  After 2-3 d in vitro the cultures were washed twice with Dul- 
becco's PBS and fixed with 2.5 % (vol/vol) gluUu'aldehyde in PBS for 30 rain 
at room temperature.  The growth pattern of the axons was examined with 
an inverted  microscope,  equipped  with phase contrast optics  (diaphot; 
Nikon, Japan). 
To localize  the added Fab fragments at the electromnicroscopic  level, 
dorsal  root ganglia  (DRG)  were  grown on polylysine-coated  cover slips 
(thermanox, Lux, Division of Miles Laboratories Inc., Naperville, IL). Af- 
ter 2-3 d, the DRG were washed extensively and fixed with 2.5 % glntaralde- 
hyde in 0.12 M sodium phospbate, pH 7.3, for 30 rain at room temperature, 
rinsed twice with the same buffer, and incubated for 30 rain in a blocking 
solution containing 20 mM lysine in 0.1 M sodium phosphate, pH 7.3. After 
incubation with 0.3% gelatin (type A from porcine skin; Sigma Chemical 
Co.),  10% horse serum (Amimed AG, Basel, Switzerland)  in 0.12 M so- 
dium phosphate, pH 7.3 (incubation buffer) for 30 rain, peroxidase-con- 
jugated goat anti-rabbit IgG (Bio-science-products  AG,  Emmenbriicke, 
Switzerland)  was diluted to a final concentration of 24/~g/mi and incubated 
overnight at room temperature.  Cultures were washed extensively with the 
incubation buffer (3  x  20 min), followed by three washes with 0.12 M so- 
dium phosphate, pH 7.3. Peroxidase activity was localized by reaction with 
freshly prepared 0.05%  (wt/vol)  3,3~iiaminobenzidine-4HCI  (Serva Fine 
Biochemicals, Heidelberg,  FRG), 0.01% H202 in 100 mM NaCI, 50 mM 
Tris-HCl, pH 7.3. Cultures were postfixed with 1% osmiumtetroxide  (Serva 
Fine Biochemicals)  for 1 h and treated  with 1% uranyl  acetate  (Merck, 
Darmstadt, FRG) in 50 mM sodium acetate, pH 5 for 2 h at 4°C. Cultures 
were dehydrated and embedded in Epon 812 (Fiuka,  Buchs, Switzerland). 
Metabolic Labeling of  Cell-bound and Released 
Axonin-1 of Cultured DRG Neurons 
Proteins were metabolically  labeled in the presence of 5% horse serum and 
5% chicken embryo extract.  For long term labeling,  [3H]leucine proved 
less harmful to the cells than [35S]methionine. The medium for [3H]leucine 
labeling was  composed of leucine-free  growth  medium substituted  with 
100 #M unlabeled leucine and 0.2 to 0.25 mCi/ml [3H]ieucine.  [3H]leu- 
cine, purchased at 1 mCi/ml (New  England Nuclear,  Boston,  MA), was 
dried by vacuum centrifugation (Speed Vac concentrator; Savant, Farming- 
dale, NY) in the presence of a  1/10 vol of MEM (without  sodium bicar- 
bonate and L-leucine) and redissolved  in a 1/10 vol of H20. The osmolarity 
of this medium was 325  =t:  10 mosM. The concentrated [3H]leucine was 
stored  at -70°C until required.  For [35S]methionine labeling,  the growth 
medium contained 25  ~tM unlabeled amino acid and 0.2-0.25  mCi/ml 
[35S]methionine (New England Nuclear). 
Conditioned media were collected and the cells were washed three times 
with 2 ml of fresh medium. The medium of the first wash step was added 
to the conditioned medium. All solutions were buffered by the addition of 
1/10 vol of 200 mM Hepes,  pH 7.2. For the immunoprecipitation  of meta- 
bolically labeled axonin-l, 500 pl of vitreous fluid containing ,~1-2 pg of 
unlabeled axonin-l, were added to all conditioned media as a carrier.  The 
volume was adjusted to 4.5 ml and the samples were centrifuged at 100,000 g 
for 1 h (50 Ti; Beckman Instruments, Inc., Palo Alto, CA; 40,000 rpm) to 
remove cells and cell debris. For immunoprecipitation, the medium was ad- 
justed to 150 raM NaCI,  5 mM EDTA,  1% (wt/vol) Triton X-100, 50 raM 
Tris-HCI,  pH 7.5 by the addition of a  10-fold concentrated stock solution, 
and 0.1  ml of rabbit anti-axonin-I antiserum was added.  After incubation 
overnight at room temperature,  100 pl of a  suspension (1  vol/9 vol) of 
glutaraldehyde-fixed Staphy/ococcus aureus in 150 mM NaC1, 5 mM EDTA, 
I% (wt/vol) Triton X-100, 50 mM Tris-HC1, pH 7.5 was added, and incuba- 
tion continued for 2 h at room temperature.  Bound antigen-antibody com- 
plexes were released  by boiling for 5 rain in 60 pl of SDS-PAGE sample 
buffer. 
For the isolation of cell-bound axonin-l, the washed cells were solubilized 
by the addition of I mi of a solution containing 1% (wt/vol) SDS, 25 mM 
EDTA, 50% (vol/vol) vitreous fluid in Dulbecco's PBS (Ca2+-,Mg2+-free), 
preheated to 90°C in a water-bath.  Undissolved material was collected with 
a rubber policeman. The pooled samples were sonicated for 15 min and sub- 
sequently heated in a boiling water bath for 3 rain. To reduce SDS to a con- 
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ples were diluted with 4 vol of 2% NP-40, 25 mM EDTA, 0.3 M NaCI,  10 
mM sodium phosphate, pH 7.4, and shaken gently for 1 h at room tempera- 
ture. After centrifugation for I h at 100,000 g (50 Ti; Beckman Instruments, 
Inc., 40,000 rpm), the immunoprecipitation was carried out as described 
above, except that the volumes of the antisera and Staphylococcus aureus 
suspensions were twice that in the above procedure. 
The immunoprecipitated proteins were separated by SDS-PAGE on 7.5% 
gels. To locate axonin-l, the gels were quickly stained with Coomassie bril- 
liant blue (Serva Fine Chemicals) and a fluorographic replica was made to 
check for the purity of the immunoprecipitation. Fluorography was carried 
out according to the manufacturer's recommendations, using a  commer- 
cially available  enhancer (En3Hance;  New England Nuclear), and exposure 
to medical x-ray films (Fuji, Japan) was for 3 d at  -70°C. Protein bands 
corresponding to axonin-I were cut out from the gels, rehydrated, and in- 
cubated for 2 d at room temperature in a mixture of 10 vol of Lipoluma (Lu- 
mac/3M, Schaesberg, The Netherlands), 1 vol of Lumasolve (Lumac/3M), 
and 0.2 vol of water and counted in a liquid scintillation counter (Kontron, 
Zurich, Switzerland). 
External Biotin Labeling of Cultured DRG Neurons 
and AJ~inity Chromatography on Streptavidin-Agarose 
Externally accessible proteins of intact DRG neurons in dissociated culture 
were covalently modified with the amino group-specific reagent biotin-X- 
NHS (Calbiochem-Behring Corp., San Diego, CA) (Hare and Lee, 1989; 
Boxberg, 1987).  The conditioned medium was removed, and the cells were 
washed three times with biotinylation buffer (116 mM NaCI, 5.4 mM KCI, 
0.8 mM MgCI2,  1.4 mM CaCI2 in 26 mM sodium bicarbonate buffer, pH 
7.2).  The osmolarity was adjusted to 325 mosM by the addition of D-glu- 
cose. A stock-solution of 3 mg/mi biotin-X-NHS in water-free DMSO was 
diluted to a final concentration of 30/~g/ml in biotinylation buffer.  Incuba- 
tion with the labeling reagent was for 2  min at 37°C.  The reaction was 
stopped by removal of the labeling medium and the addition of 2 ml MEM. 
Biotinylated cells were washed twice with PBS and dissolved in 0.5 ml 
1% (wt/vol) SDS, 5 mM EDTA, 50% (vol/vol) vitreous fluid in Dulbecco's 
PBS  (Ca  2+-, Mg  2+-  free), preheated to 90°C.  The tissue culture dishes 
were rinsed with an additional 0.5 ml of 1.1% NP-40, 5 mM EDTA, 50% 
vitreous fluid in Dulbecco's PBS (Ca  2+-, Mg2+-free).  The samples were 
pooled, sonicated, heated for 3 min in a boiling water bath, and stored at 
-70°C until required. 
Biotinylated  proteins were isolated by affinity chromatography on Strepta- 
vidin-agarose. The solubilized cellular proteins were centrifuged at 100,000 g 
for I h and subsequently incubated for 16 h at room temperature with 100 t~l 
of a suspension of Streptavidin-agarose (Sigma Chemical Co.). After cen- 
trifugation, removal of the supernatant (unbound fraction), and extensive 
washing of the gel with 150 mM NaCI, 5 mM EDTA,  1% (wt/vol) Triton 
X-100, 50 mM Tris-HCl, pH 7.5, biotinylated proteins were eluted with 1 ml 
of 1% (wt/vol) SDS, 25 mM EDTA, 50% vitreous fluid in Dulbecco's PBS 
(Ca  2+-, Mg  2+- free). To reestablish conditions permissive for antigen-anti- 
body complex formation, 4 ml of 2% (wt/vol) NP-40, 25 mM EDTA, 0.3 
M NaCI, 10 mM sodium phosphate, pH 7.4 were added to the eluted mate- 
rial. Both the bound and the unbound fraction were subjected to immuno- 
precipitation and quantification of the radioactivity incorporated into axon- 
in-l, as described above. 
As a control for the protection of intracellular proteins, biotinylation of 
cytosolic aspartate aminotransferase was assessed using the same protocol 
as for axonin-l. Polyclonal rabbit antiserum against cytosolic aspartate ami- 
notransferase and pure chicken cytosolic aspartate aminotransferase, used 
as a carrier, were provided by Dr.  H. Gehring. 
Preparation and Subfractionation of  Brain Membranes 
Brain membranes from  10-14-d-old chicken embryos were prepared ac- 
cording to Hoffman et al. (1982).  Brains were removed and washed at 4°C 
in 137 mM NaCI, 2.7 mM KCI, 8.1 mM Na2HPO4.  1.5 mM KH2PO4,  1 
mM CaCI2,  1 mM MgCI2, pH 7.4.  For homogenization and all the follow- 
ing centrifugation steps, a mixture of protease inhibitors (all from Sigma 
Chemical Co.) was added to a final concentration of 0.5 mM PMSE 5/tM 
pepstatin A, 10 I~M leupeptin, and 1% (vol/vol) aprotinin (protease inhibitor 
buffer, PIB). Tissue disruption was carried out using a Dounce homogenizer 
with six strokes of the loose and three strokes of the tight pestle. After cen- 
trifugation for 15 rain at 40,000  g (SS-34; Sorvall Instruments Div., New- 
ton, CT; 20000 rpm), the volume of the pellet was measured and 2 vol of 
2.25 M sucrose in PIB were added. The suspension was placed in centrifuge 
tubes and each aliquot was overlaid with 1/3 vol of 0.8 M sucrose. After 
centrifugation at 100,000 g  (%865;  Sorval Instruments Div., 38,000  rpm) 
for  1 h,  the material at the interface was collected, washed twice, and 
resuspended in PIB. After determination of  the protein concentration, buffer 
was added to give a final protein concentration of ,,o 25 mg/ml. All proce- 
dures were carried out at 4°C; if not used immediately, the membrane sus- 
pension was stored at  -70°C. 
Before membrane subfractionation, soluble axonin-1, sequestered in mem- 
brane vesicles, was released by sonication in an ice-hath (Kreibich and 
Sabatini,  1974) using a  sonifier equipped with a  microtip (sonifier 250; 
Branson Sonic Power Co., Danbury, CT). Sonication was carried out in five 
periods of 20 pulses (40 watts, 0.5 s) allowing l-rain intervals for cooling. 
Sonicated membranes were isolated by centrifugation at 100,000 g for 1 h 
at 4°C. To solubilize peripherally adhered proteins, membranes were con- 
secutively exposed to mild and harsh release conditions. Protein release un- 
der mild conditions was in 1 M NaCI in PIB for 90 min at 4°C, followed 
by centrifugation at 100,000 g for I h at 4°C. Release under harsh conditions 
was at high pH (Steck and Yu,  1973).  In using a buffered solution we fol- 
lowed the suggestion of Fujikl et ai. (1982),  however, 50 mM triethylamine, 
pH 11.5, was preferred to sodium carbonate (Snow et al., 1988).  Incubation 
in 50 mM triethylamine, pH 11.5, in the presence of the protease inhibitors, 
was for 90 rain at 4°C, and a centrifugation at 100,000 g for 1 h at 4°C fol- 
lowed. The pellet of the stripped membranes was resuspended by the addi- 
tion of PIB to a final protein concentration between 2-4 mg/ml. Extraction 
of membrane proteins was carried out by the addition of I vol of  2 % (wt/vol) 
3-(3-cholamidopropyl)dimethyl-ammonio-l-propane  suifonate (CHAPS) in 
PIB with gentle shaking for 90 rain at 4°C. Undissolved material was re- 
moved by centrifngation at 100D00 g for I h at 4°C and solubilized in hot SDS. 
ImmunoaJ~nity Chromatography of  Axonin-1 
For isolation of the integral membrane form of axonin-l, CHAPS-solu- 
bilized proteins of stripped brain membranes were passed through immuno- 
affinity columns  with  immobilized rabbit polyclonal anti-axonin-I  IgG 
(CNBr-activated Sepharose; Pharmacia Fine Chemicals; containing ,'~5 mg 
of IgG per milliliter packed gel). After binding, the columns were washed 
with at least 40 column vol of 1% CHAPS, 300 mM NaCI, 2.7 mM KCI, 
8.1 mM Na2HPO4,  1.5 mM KH2PO4,  1 mM CaCI2,  1 mM MgCI2, pH 7.4 
including the mixture of protease inhibitors. Bound antigen was eluted with 
50 mM diethylamine, 0.5% CHAPS, pH 11.5. The eluate was neutralized 
immediately by the addition of 1/10 vol of 1 M Tris-HCl, pH 7.0. All proce- 
dures were carried out at 4°C. 
Protein Determinations 
Concentrations of soluble protein in the range of 0.2-1.2 mg/ml were deter- 
mined according to Bradford (1976), using a commercially available product 
(Bio-Rad Protein Assay; Bio-Rad Laboratories, Richmond, CA). Protein of 
brain membrane suspensions was quantified using a  modification of the 
Bradford procedure adapted  for  measurements in the presence of SDS 
(Rubin and Warren, 1977).  Lower protein concentrations were determined 
after modification with fluorescamine (Fluram; Roche, Basel, Switzerland) 
as described by B6hlen et al. (1973).  BSA was used as a standard. 
Electrophoretic Procedures 
SDS-PAGE was carried out according to Laemmli (1970).  Two-dimensional 
SDS-PAGE was performed according to O'Farrell (1975) under previously 
detailed conditions (sonderegger et al.,  1985).  For fluorography (Bonner 
and Laskey,  1974),  a commercially available acetic acid-based enhancer 
(En3Hance; New England Nuclear) was used. Silver staining was accord- 
ing to Switzer et al. (1979) as modified by Oakley et al. (1980).  Radioactive 
molecular mass markers were the ['4C]methylated forms of cytochrome c 
(12 kD), carbonic anhydrase (30 kD), albumin (69 kD), phosphorylase (97 
kD), and myosin (200 kD) (all from New England Nuclear and mitochon- 
driai aspartate aminotransfemse (45 kD) alkylated with [ 14C]N-ethylmale- 
imide; for silver stained gels, cytochrome c (12 kD), carbonic anhydrase 
(30 kD), ovaibumin (45-46 kD), albumin (69 kD), phosphorylase (97 kD), 
~galactosidase (116 kD), myosin (200 kD) (all from Sigma Chemical Co.) 
were used. In some gels (Fig. 3, A and B), the marker proteins were sup- 
plemented with RNA polymerase (Pierce Chemical Co., Rockford, IL) dis- 
playing subunit bands at  165, 155, and 39 kD. 
Peptide Mapping and Deglycosylation 
Peptide mapping of soluble and membrane-associated axonin-I was carried 
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rated by SDS-PAGE on a 5% gel. After visualization of protein bands by 
a short staining with Coomassie blue, axonin-I bands were cut out of the 
gel and equilibrated in 0.1%  (wt/vol) SDS,  1 mM EDTA,  10%  (vol/vol) 
glycerol, 0.3% (vol/vol)/~-mereaptoethanoi, 125 mM Tris-HCl, pH 6.8 for 
1 h. The gel pieces containing axonin-I were loaded on a SDS-PAGE gra- 
dient gel (10-17.5 % acrylamide). For partial proteolytic digestion during 
electrophoresis, endoproteinase GIu-C (EC 3.4.21.19,  from Staphylococcus 
aureus VS; Boehringer Mannheim GmBH, FRG) was added at either 0.1% 
or 0.5% (wt/wt). To enhance proteolysis, electrophoresis was stopped for 
10 rain when the proteins were most concentrated at the intcrphase between 
stacking and separating gel. The resulting peptide fragments were visual- 
ized by silver staining. 
For the enzymatic deglycosylation with glycopeptidase F (peptide N-gly- 
cohydrolase E  EC 3.2.2.18,  from Flavobacteriwn meningosepticum; Boehr- 
inger Mannheim), 3/~g of  soluble or membrane-bound axonin-1 were precipi- 
tated in chloroform/methanol OVessei and Flungge,  1984), and redissolved in 
1% SDS, 5% /~-mercaptoethanol,  50 mM EDTA in 20 mM sodium phos- 
phate, pH 7.2, preheated to 90°C. After dilution of the sample to 0.2% SDS, 
1% ~-mereaptoethanol, Triton X-100 was added to give a final concentration 
of 1% (wt/vol) Triton X-100. Deglycosylation was started by the addition of 
1 U of glycopeptidas¢ E  Incubation was at 37°C for 24 h. 
Immunoblotting 
Proteins were resolved by  one- or two-dimensional SDS-PAGE.  Electro- 
transfer onto nitrocellulose (Schleicher and Schuell, Dassel, FRG) was car- 
tied out according to Towbin et al. (1979) at 40 V  for 16 h and 4°C. Im- 
munodetection of antigens was performed as described by Hawkes et al. 
(1982).  To increase the sensitivity when monocional antibodies were used, 
a modified procedure involving a bridge antibody between the antigen-specific 
and the peroxidase-conjugated antibody was applied. After incubation of the 
antigen-specific monoclonal antibodies overnight at 4°C, an affinity-purified 
antibody against  mouse  IgG  (goat anti-mouse IgG;  Kirkegaard  &  Perry 
Laboratories Inc., Gaithersburg, MD) was incubated at a concentration of 5 
/tg/ml for 6 h at room temperature. Subsequently, a peroxidase-conjngated  an- 
tibody against goat IgG (rabbit anti-goat IgG, peroxidase conjugated; Bio- 
science-products AG) was added and the incubation carried on overnight at 
4°C. The peroxidase-reaction was with 0.01% H202 (Fluka AG, Buchs, Swit- 
zerland), 0.5  mg/ml 4-chloro-naphthol (E.  Merck, Darmstadt, FRG), 200 
mM NaCl in 50 mM Tris-HCI, pH 7.4. The reaction was stopped by washing 
the nitrocellulose with distilled water. Antisera against axonin-l, raised in rab- 
bit or goat, were diluted  1/4,000, and monoctonal antibodies from ascitic 
fluids were diluted 1/1,000. HNK-I was used as the undiluted culture superna- 
rant of the mouse-mouse hybridoma (ATCC TIB 200; American "Pype Cul- 
tore Collection, Rockville,  MD). L2 and L3 were used as the undiluted cul- 
tore supernatants  of rat-mouse bybridomas (provided by Dr. M. Schachner). 
Polyclonal rabbit IgG against N-CAM and Ng-CAM (provided by Dr. G. M. 
Edelman and coworkers) were used at a concentration of  20 #g/ml. Polyclonal 
lgG against G4, FI 1, and neurofascin (provided by Dr. E Rathjen and cowork- 
ers) were used at a concentration of 25 #g/ml. 
Ouchterlony Double Diffusion Test 
For the Ouchterlony double diffusion-in-gel  technique (Nilsson, 1983),  1.5% 
agarose in PBS was heated to 95°C and poured onto 20 x  65-ram glass slides 
to a thickness of 3 mm. After congelation, the coated slides were stored in 
a humid chamber at 4°C. Immediately before use, 3-ram-wide circular basins 
were punched out and filled with antigen or antiserum solutions.  Incubation 
was for 48 h at 4°C. 
ELISA 
ELISA was performed as previously described (Ruegg et al.,  1989).  All 
measurements were carried out in 300 mM NaCI, 5 mM EDTA, 1% Triton 
X-100, or  1% CHAPS, 50 mM Tris-HCl, pH 7.5.  The concentration of 
axonin-1 used for the calibration curves of ELISAs was determined by mea- 
surement of the absorption at 220  nm (EmM ---- 1,850, as determined by 
amino acid analysis). The results obtained by ELISA were in good agree- 
ment with the estimations based on immunoprecipitation, followed by SDS- 
PAGE and silver staining, where the relative intensity of axonin-I was deter- 
mined by comparison with a dilution series of a  known quantity of pure 
axonin-1. 
Results 
Axonin-l-like Immunoreactivity Is Associated with 
Developing Nerve Fiber Tracts 
To localize axonin-1  in developing central nervous tissue, 
cryostat sections of aldehyde-fixed tissue were subjected to 
indirect immunofluorescence staining. In 5.5-d embryonic 
chicken retina, the optic fiber layer was intensely stained, 
weaker staining of diffuse appearance was found in the de- 
veloping inner plexiform layer (Fig. 1, A and C). In 8-d em- 
bryonic  spinal  cord,  axonin-l-like  immunoreactivity was 
most intense in the dorsal  funiculus, weaker staining oc- 
curred in the dorsal roots and the dorsal root ganglia (Fig. 
1, B and D). No fluorescence was detected with preimmune 
serum used at the same dilution (Fig.  1,  E  and F).  With 
monoclonal antibodies against axonin-1,  the same staining 
pattern was obtained (not shown), hence, a specific axonin- 
l-like immunoreactivity was involved. 
Predominant association with nerve fiber tracts is typically 
found with a group of adhesive glycoproteins, termed axon- 
associated adhesion molecules (AxCAMs), because of their 
topographic restriction to axonal membranes of nerve fiber 
tracts (Rutishauser and Jessel, 1988). In the retina, the stain- 
ing pattern of  axonin-1 was virtually identical to that reported 
for Ng-CAM (Thiery et al., 1985; Daniloffet. al, 1986), G4 
(Rathjen et al.,  1987a),  and 8D9 (Lemmon and McLoon, 
1986),  whereas the reported immunoreactivity of neurofas- 
cin is distinct from axonin-1 by its confinement to the inner- 
most part of the optic fiber layer (Rathjen et al.,  1987b).  In 
the spinal cord at embryonic day 5 or 6, the immunoreac- 
tivity for axonin-1 is virtually restricted to the dorsal funicu- 
lus, whereas the reported immunoreactivity pattern for Ng- 
CAM (Thiery et al.,  1985;  Daniloff et al.,  1986)  and (34 
(Rathjen et al., I987b) also includes the white matter of the 
ventral horn. The distribution of neurofascin in the spinal 
cord was reported to be even more widespread, including the 
dorsal  and ventral  funiculus and the  ventral commissure 
(Rathjen et al.,  1987b). 
Fab Fragments of  Anti-Axonin-1 Antibodies Bind to 
Growing Axons and Perturb Their Fasciculation 
As a  first step in the investigation on a  functional role of 
axonin-1 in cell adhesion, an antibody perturbation assay of 
axon fasciculation was chosen. The specificity of the poly- 
clonal rabbit antibodies used has been documented under a 
variety of conditions (Ruegg et al., 1989; this paper); of par- 
ticular pertinence, no reactivity to proteins in the molecular 
weight range of  the chicken cell adhesion molecules involved 
in axon fasciculation was detectable with these antibodies by 
immunoaffinity  chromatography of  brain membrane proteins 
under native conditions (see Fig. 3 A, lane/). In all of eight 
independent  perturbation  experiments,  the  presence  of 
anti-axonin-1 Fab fragments in the medium of dorsal root 
ganglia cultures during the period of axon extension had a 
dramatic  impact  on  the  axonal  growth  pattern  (Fig.  2). 
Axons grown in the absence of antibodies formed fascicles 
with obvious radial orientation (Fig. 2 B). The presence of 
Fab  fragments during axon elongation resulted in  a  fine 
meshwork of relatively thin fascicles (Fig. 2 A); most nota- 
bly, the radial orientation of the axon fascicles, observed un- 
The Journal  of Cell Biology,  Volume 109, 1989  2366 l~gure L Immunohistochemistry  localizes axonin-I in nerve fiber tracts. Aldehyde-fixed frozen sections of 8-d-old embryonic retina (A, 
C, and E) and 5.5 d-old embryonic spinal cord (B, D, and F) were subjected to indirect immunofluorescence staining using anti-axonin-1 
antiserum and FITC-conjugated second antibodies. A and B, phase optics.  C and D, anti-axonin-1 antiserum.  The arrows in C indicate 
the optic fiber layer (OFL) and the inner plexiform layer (IPL), respectively. The arrows in D indicate the dorsal funiculus (DF) and the 
dorsal root ganglion (DRG), respectively. E and F, controls with preimmune serum at the same dilution as immune serum. Bars: (A, C, 
and E) 60 tLm; (B, D, and F)  150 #m. 
der standard culture conditions, had virtually disappeared.. 
At higher magnification (Fig. 2, C and D), a markedly finer 
texture of the axonal meshwork (Fig. 2 C) was the most obvi- 
ous effect observed when axons were grown in the presence 
of anti-axonin-1 Fab fragments. A  reduction of the fascicle 
diameter was less striking, yet clearly reproducible. If thin 
fascicles at the periphery of the ganglia were inspected, an 
increased tendency of single fibers to branch off their fasci- 
cle was obvious. 
The ultrastructural location at the end of a perturbation ex- 
periment of the added Fab fragments was determined by im- 
munoelectron  microscopy  using  a  peroxidase-conjugated 
second antibody (Fig. 2, E and F). Intense staining of axonal 
membranes in axon fascicles was found (Fig. 2 E), suggest- 
ing a membrane-bound form of axonin-I as the site of action 
in perturbing fasciculation. 
Membrane-associated  Axonin-1 Comprises a Major 
Integral Membrane Protein and a Minor Peripheral 
Membrane Component 
The nature of membrane association of axonin-I was inves- 
tigated on sonicated brain membranes prepared from 14-d- 
old chick embryos by consecutive exposure to selected re- 
Ruegg et al. Axonin-1  Is Involved in Neurite Fasciculation  2367 Figure 2.  Anti-axonin-I  Fab fragments bind to axonal membranes and perturb neurite fasciculation.  Dorsal root ganglia were cultured 
in the presence of 100/~g/ml of anti-axonin-I  Fab fragments (A, C, and E) or Fab fragments isolated from nonimmune sera, respectively 
(B, D, and F). After 2 d in culture, cells were fixed with 2.5 % glutaraldehyde and the growth pattern of axons was examined on an inverted 
microscope, equipped with phase contrast optics. A and C, axon growth pattern obtained in the presence of Fab fragments against axonin-l. 
Note the virtual absence of a clear radial orientation (A) and the fine texture of the axonal meshwork (C). B and D, axon growth pattern 
in the presence of nonimmune Fab fragments. Note the thicker fascicles with predominantly radial orientation (B) and the coarse texture 
of the axonal meshwork (D). E and F, immunoelectron microscopic localization of Fab fragments at the end of a perturbation experiment. 
E, axons grown in the presence of anti-axonin-1 Fab fragments. F, axons grown in the presence of nonimmune Fab fragments. Bars: (A 
and B) 200/Lm;  (C and D) 40 ~m; (E and F) 0.25 ~m. 
lease conditions  (TaMe I).  The high-salt and  the  high-pH 
procedures together removed 37 %  of the  axonin-1.  About 
two-thirds of the membrane-bound axonin-1 were refractory 
to extraction by high salt and high pH, but were solubilized 
in the presence of CHAPS, and hence, by operational defini- 
tion, are integral membrane protein. No axonin-I was found 
among the remaining proteins that could only be solubilized 
by hot SDS. 
The highest specific concentration of axonin-1 was deter- 
mined in the CHAPS-extractable fraction. Specific concen- 
trations in the high-salt and high pH-extracted fractions were 
lower by a factor of five and twelve, respectively. Obviously, 
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Axonin-1 
Protein  Axonin-I  Specific  concentration  of 
Solubilization  in supernatant  in supernatant  axonin-i  in superoatant 
mg  izg  %  ng/mg protein 
Total  907  73  100  - 
1 M  NaC1  91  9  12  99 
pH  11.5  425  18  25  42 
1%  CHAPS  91  46  63  506 
1%  SDS  300  <0.1  <0.1  <0.3 
Brain membranes from 14-d-old chicken embryos were resuspended at a pro- 
tein concentration of 27 mg/ml. Soluble axonin-1 enclosed in membrane vesi- 
cles  (14  /~g) was  released  by  sonication.  The  sonicated  membranes  were 
consecutively exposed to I M sodium chloride,  to 50 mM triethylamine,  pH 
I 1.5, to ! % CHAPS, and to 1% SDS. After each step of this sequence, mem- 
branes were centrifuged for 1 h at 100,000 g at 4°C and the concentration of 
protein and axonin-1 determined in the supernatant; the pellet was resuspended 
in the appropriate  solution for the next step.  Quantification of axonin-I  was 
performed with ELISA, except for the SDS fraction, where immunoprecipita- 
tions using polyclonal rabbit anti-axonin-I  antibodies and glutaraidehyde-fixed 
Staphylococcus aureus were carried out after dilution to 0.2 % SDS and the ad- 
dition of Triton X-100 to a sixfold excess (wt/vol) over SDS. Precipitates were 
subjected to SDS-PAGE and silver  staining,  and the bands corresponding  to 
axonin-I were quantified with a series of  purified axonin-I  standards. The same 
immnnoprecipitation  procedure  was also used for a validation of the ELISA 
data. The proportions  of axonin-I  in the vesicular, peripheral  membrane, and 
integral membrane protein fractions were in close agreement with those deter- 
mined by ELISA. 
the surface-bound and the integral membrane proteins are 
populations of markedly distinct composition. Furthermore, 
the 12-fold higher specific concentration of axonin-1  in the 
integral membrane protein fraction as compared with the 
high pH-released  proteins clearly indicates that axonin-1 
found in the integral membrane fraction does not represent 
a contamination due to incomplete removal of the surface ad- 
sorbed proteins. 
Axonin-1 of the Integral Membrane Protein Fraction Is 
Highly Similar,  Yet Not Identical, to Soluble Axonin-1 
The high-salt and high pH-resistant form of axonin-1  ex- 
tracted from stripped membranes by 1% CHAPS in the pres- 
ence of  protein inhibitors migrated slightly faster in SDS-PAGE 
on a 7.5 % gel and its relative molecular mass was estimated 
to be 128 kD, i.e., "~2 kD lower than the relative molecular 
mass of its soluble counterpart (Fig. 3 A).  Digestion with 
glycopeptidase F resulted in a reduction of the apparent mo- 
lecular mass by ,x,15  % in both soluble and membrane-bound 
axonin-1  (Fig. 3 B). The estimated relative molecular mass 
of deglycosylated membrane-bound axonin-1  was  115  kD, 
that of the soluble form •117  kD. Hence, a molecular mass 
difference of 2 kD was also present after enzymatic removal 
of N-linked carbohydrate. 
Several pieces of evidence indicate that the soluble and the 
integral membrane forms of axonin-1 are highly similar pro- 
teins. (a) A comparison by means of  the Ouchterlony double- 
diffusion test revealed immunological identity, as indicated 
by the complete fusion of the precipitin lines (Fig. 3 C). (b) 
Soluble and membrane-bound axonin-1  are  also  indistin- 
guishable with respect to the number and the pI of their iso- 
electric variants, as revealed by two-dimensional SDS-PAGE 
(not shown). (c) The peptide maps generated by partial pro- 
teolytic cleavage according to Cleveland (1983) add further, 
independent evidence for a high degree of similarity between 
the soluble and the integral membrane forms of axonin-1. As 
demonstrated in Fig. 3 D, 26 peptides between 140 and 13 
kD resulted from partial proteolytic cleavage with endopro- 
teinase Glu-C, 25 peptides being present in both samples. 
One peptide of'~ 22 kD (arrow in Fig. 3/9) was only discern- 
able in the maps derived from membrane-bound axonln-1. 
Axonin-1 Is Distinct from other Adhesive 
Giycoproteins of the Nervous System 
Axonin-1  was  compared  with the  neuronal cell adhesion 
molecules of the chicken reported to be associated with neu- 
ronal membranes of nerve fiber tracts and involved in axon 
fasciculation, namely N-CAM, Ng-CAM, (34, Fll, and neu- 
rofascin (Fig. 4). A comparison with Ng-CAM and N-CAM 
is shown in the upper three sections of Fig. 4. Both the solu- 
ble  and the  integral membrane form of axonin-1  showed 
strong reactivity with polyclonal anti-axonin-1 (Fig. 4 A). A 
strong axonin-1  immunoreactive band was revealed in the 
vitreous fluid of the eye, whereas the axonin-l-reactive com- 
ponent of the stripped brain membranes was only repre- 
sented by a relatively faint band. Neither polyclonal anti-Ng- 
CAM nor polyclonal anti-N-CAM recognized either form of 
axonin-1  (Fig. 4, B and (7,  respectively). With polyclonal 
anti-Ng-CAM (Fig. 4 B, lane BM) and anti-N-CAM anti- 
bodies (Fig. 4  C, lane BM) strong immunoreactivity with 
abundant protein bands of the molecular mass expected for 
Ng-CAM (Grumet et al.,  1984) and N-CAM (Rothbard et 
al., 1982; Daniloff  et al., 1986), respectively, were detected 
in brain membranes and faint immunoreactivity at the same 
migratory distance was also observed in the vitreous fluid. 
The immunoblot analysis for immunological cross-reac- 
tivity of axonin-1 with G4, FII, and neurofascin is shown in 
the lower three sections of Fig. 4. None of the polyclonal an- 
tisera against (34 (D), Fll (E), and neurofascin (F) showed 
cross-reactivity with soluble axonln-1 or its membrane-bound 
homologue. Again, as a positive control, the staining pattern 
of the corresponding immunogen was determined, however, 
the purified immunogen was used. In all three cases, the ob- 
tained band pattern was identical with that reported in the 
literature (for G4 and Fll cf. Rathjen et al., 1987a; for neu- 
rofascin cf. Rathjen et al.,  1987b). 
Axonin-1 Has the L2/HNK-1 and the L3 Epitopes in 
Common with other Adhesive Glycoproteins 
A  typification of axonin-1  for adhesion molecules specific 
carbohydrate structures (Kruse et al., 1984; Kiicherer et al., 
1987) revealed expression of the L2/HNK-1 as well as the L3 
epitope on both the soluble and the membrane-bound forms 
(see Fig. 5, for an illustration).  Two-dimensional SDS-PAGE/ 
immunoblotting further demonstrated the presence of the 
L2/HNK-1 epitope on all the isoelectric variants (Fig. 5 B). 
Pulse-labeling and Pulse-Chase Experiments Reveal 
Two Ceil-associated  Forms of  Axonin-l, One with Fast 
and One with Slow Turnover 
As a primary step to address the question whether soluble 
axonin-1 was derived from the membrane-bound form or in- 
dependently secreted,  the turnover of cellular axonin-1  of 
cultured  neurons  was  determined  by  pulse-labeling  and 
pulse-chase experiments (Fig. 6). Preliminary experiments 
yielded evidence for a rapidly and a slowly saturating form 
Ruegg et al. Axonin-I  Is Involved in Neurite Fasciculation  2369 Figure 3. The soluble and the integral membrane forms of axonin-1 are very similar,  but not identical.  Soluble axonin-I (Axs) was purified 
from the vitreous fluid of El4 chicken embryos; the integral  membrane form of axonin-1 (Axm) was isolated  from stripped  brain mem- 
branes of 14-d-old chicken embryos by CHAPS solubilization  in the presence of protease inhibitors  and immunoaflinity  chromatography. 
A, a comparison of apparent molecular mass of Axs and Axm. SDS-PAGE, 7.5% with silver staining.  Lane 1, 0.25 t~g Axm; lane 2, 0.25 
#g Axe; lanes M, molecular mass markers.  B, a comparison of the apparent molecular mass of Axs and Axm after enzymatic removal of 
N-linked  glycans using glycopeptidase E  5% SDS-PAGE followed by silver staining.  Lanes 1 and 5, Axm and Axs, respectively;  lanes 2 
and 4, N-deglycosylated Axm and Axs,  respectively;  lane 3,  eomigration of N-deglycosylated Axm and Axe; lanes  M, molecular mass 
markers.  C, Ouchterlony double diffusion-in-gel  test for immunological comparison of soluble and membrane-bound axonin-l.  Well 1 con- 
tains 30 t~l of rabbit anti-axonin-1  antiserum at a dilution of 1:10. 30 tzl of Axm (70 tzg/ml) was added to well 2 at the beginning and after 
12 and 24 h of incubation.  Axs was added to well  3 in three portions as for the integral  membrane form. Note the complete fusion of 
the precipitin  lines.  Absence of spurs was verified by microscopic inspection  using dark field optics with a stereomicroscope (MS, Wild- 
Leitz). D, peptide  maps of Axs and Axm according to Cleveland  (1983).  Lane 1, undigested  Axm; lane 2, Axm digested  with 0.5%  of en- 
doproteinase GIu-C; lane 3, Axs digested with 0.5%  of endoproteinase GIu-C; lane 4, Axm digested  with 0.1% of endoproteinase  GIu-C; 
lane 5, Ax~ digested with 0.1% of endoproteinase GIu-C; lane 6, undigested  Axe. All peptides  generated  from Ax~ are also present in Axm; 
one additional  peptide  band occurs only in the cleavage product of AXm (arrow). 
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logically distinct  from other axon- 
associated cell adhesion molecules 
of nerve fiber tracts.  (A,  B,  and 
C)  The cross-reactivity of puri- 
fied soluble and membrane-bound 
axonin-1 with polyclonal antibod- 
ies against N-CAM and Ng-CAM 
was investigated by immunoblot 
analysis; as positive controls, the 
immunoreactivity of the antibod- 
ies with membrane preparations 
was determined. Identical sets of 
proteins  (lanes  1-4 of each sec- 
tion) were subjected to 7.5% SDS- 
PAGE followed by electrotransfer 
onto  nitrocellulose.  Reactivity 
with polyclonal antibodies against 
axonin-1  (A),  Ng-CAM (B), and 
N-CAM (C) was visualized with 
peroxidase-conjugated  second an- 
tibodies,  lane I,  rF,, 100 txg of vitre- 
ous fluid  proteins;  lane Ax,, 0.2 
t~g of soluble axonin-1,  purified 
from vitreous fluid of the chicken 
embryo; lane Axm, ([2 t~g of mem- 
brane-bound axonin-l, isolated by 
immunoaltinity chromatography; 
lane  BM,  100  txg  of  CHAPS- 
extracted  brain  membrane  pro- 
teins. Note the prevalence of ax- 
onin-I inthe vitreous fluid, where 
only trace amounts of Ng-CAM 
and N-CAM are found. Both Ng- 
CAM  and  N-CAM  are  clearly 
predominant  in  the  brain  mem- 
branes, where only a minor band 
of axonin-1  is found.  (D, E, and 
F)  The cross-reactivity of puri- 
fied soluble and membrane-bound 
axonin-I with polyclonal antibod- 
ies against G4, F11, and neurofas- 
tin was investigated by immuno- 
blot  analysis.  Purified  G4,  Fll, 
and neurofascin were used as positive controls. (D) Test for cross-reactivity of soluble and membrane-bound axonin-1 with polyclonal anti- 
bodies against G4. Lane Ax3, 0.2 t~g of soluble axonin-1;  lane ,,Ix,, 0.2/~g of membrane-bound axonin-1;  lane G4, purified G4 glycopro- 
tein.  (E) Test for cross-reactivity of soluble and membrane-bound axonin-1  with polyclonal antibodies against Fll.  Lane Ax,,  0.2 tLg of 
soluble axonin-1;  lane Axm, 0.2 #g of membrane-bound axonin-l; lane F/l, purified Fll glycoprotein. (F) Test for cross-reactivity of solu- 
ble and membrane-bound axonin-1  with polyclonal antibodies against neurofascin. Lane Ax,, 0.2 #g of soluble axonin-l; lane Axm, 0.2 tLg 
of membrane-bound axonin-l; lane Nf, purified neurofascin. 
of cell-associated  axonin-1,  the  slowly  saturating  form re- 
quiring  several days to incorporate a  reasonable quantity of 
radioactive amino acid. The turnover rates, thus, were deter- 
mined by standard decay kinetics after an extended period of 
labeling.  Two  populations  of  axonin-1  were  found,  as 
reflected by biphasic kinetics of the decrease of radioactive 
axonin-1  after the end of the pulse  (Fig.  6).  Using the data 
of three independent  experiments,  half-lives of 5.1  h  (SEM 
=  0.4, n  =  3) and  104 h  (SEM  =  11, n  =  3), respectively, 
were calculated.  Data from decay kinetics being prone to er- 
ror introduced by isotope reuse (Schimke, 1975), the half-life 
of the  fast-turnover  form was also  determined  by  the  "ap- 
proach to equilibrium  method;  which,  for theoretical  rea- 
sons, is not affected by isotope reuse (Bradley et al.,  1976). 
Only  a  relatively  small  discrepancy  (t~/z =  4.4  h)  was ob- 
tained,  hence,  tracer  reuse  was  concluded  to  represent  a 
negligible  problem in this  dissociated  cell culture  system. 
The relative size of the two pools was determined  by ex- 
trapolation to the beginning of the chase. At this point, when 
both forms are maximally labeled,  the  radioactive  label  is 
equally distributed between the two kinetic forms. Since, af- 
ter  a  pulse  of 6  d,  the  fast-turnover  pool  is  fully  labeled, 
whereas the slow-turnover pool (tt/2 =  104 h) is labeled to 
'~70%, the estimated size of the slow-turnover pool exceeds 
that of the fast-turnover pool by a  factor close to  1.5. 
Ruegg et al. Axonin-1 Is Involved in Neurite Fasciculation  2371 Figure 5. Both membrane-associated and soluble axonin-I bear the L2/HNK-1 epitope, which has been proposed as a marker for cell adhe- 
sion molecules. (A) Immunoblots with monoclonal antibody HNK-1. lane 1,  100 #g of proteins from vitreous fluid; lane 2, 0.2 #g of 
soluble axonin-1, purified from vitreous fluid; lane 3, 0.2 #g of membrane-bound axonin-1 isolated by immunoaflinity chromatography 
from CHAPS-extracts of stripped brain membranes; lane 4,  100 #g of CHAPS-extracted stripped brain membrane proteins. (B) Two- 
dimensional immunoblots with monoclonal antibody HNK-1 and polyclonal anti-axonin-1 antibody. 3 #g of soluble axonin-I were resolved 
by two-dimensional SDS-PAGE, electrotransferred to nitrocellulose and subsequently stained with HNK-1 (top) or anti-axonin-I antibodies 
(bottom). Note that all the isoelectric variants recognized by anti-axonin-I  also bear the HNK-I epitope. 
Released Axonin-1 Is Derived from the 
Fast-Turnover Pool; the Slow-Turnover Pool Does Not 
Contribute Substantially 
To identify the form representing the pool of  origin of released 
axonin-1,  the slow-turnover and the fast-turnover forms were 
differentially labeled with [3H]leucine and [35S]methionine, 
respectively,  by  appropriately  timed  pulse-chase  double- 
labeling, and the content in each isotope of both the cellular 
and the released form was determined (Fig. 7). Virtually ex- 
clusive labeling of the slow-turnover form was obtained with 
a long-lasting pulse of [3H]leucine (4 d) followed by a chase 
of 63 h (representing >10 half-lives of the fast-turnover form). 
Beginning after 63 h  of chase,  a  pulse of [35S]methionine 
was given for 48 h. With this pulse duration, full labeling of 
the fast-turnover pool was obtained; the calculated labeling 
of the slow-turnover pool was "o20%. 
The radioactivity of [3H]leucine and [3~S]methionine found 
in cellular and released axonin-1, at various points in time 
during the pulse with [35S]methionine,  is shown in Fig. 7 A. 
In accordance with the data revealed by the decay kinetics, 
the cellular form of axonin-1  displayed a biphasic course of 
isotope incorporation.  A  fast-saturating phase preceded a 
period of virtually linear increase, interpreted to represent 
a slowly saturating second phase. Released axonin-1,  after a 
short lag, had assumed a steady rate of release. An estima- 
tion of the relative contributions of each pool to  released 
axonin-1  can be derived from a comparison of the rates of 
release with the respective pool sizes. The fast-turnover pool 
of axonin-1  contained, at saturation,  "o2,000 cpm of [35S]- 
methionine. Between 11.5 and 48 h of the [35S]methionine 
pulse,  the  [35S]methionine-labeled  fast-turnover pool  had 
released 4,200 cpm of axonin-1,  corresponding to a  daily 
release of 2,800 cpm. Hence, "ol.4 times the content of the 
fast-turnover pool is released per day. In consideration of a 
half-life of 5.1 h, an estimated 60% of the throughput of the 
fast-turnover  pool was recovered from the extracellular space. 
The slow-turnover pool of axonin-1  decreased from 3,300 to 
2,300 cpm between 63 and 111 h chase. Approximately 500 
cpm were recovered with axonin-1 accumulated in the super- 
natant during  this  48-h  period.  Hence,  the  slow-turnover 
pool releases <10%  of its content in a day. Based on these 
data,  in conjunction with the ratio of the pool sizes deter- 
mined  in  the  single-isotope pulse-chase  studies,  the esti- 
mated contribution of the fast-turnover pool to axonin-1  re- 
lease is ,o90%. 
The predominant origin of released axonin-1 from the fast- 
turnover pool is corroborated by the ratios of [35S]methio- 
nine to [3H]leucine labeling throughout this prolonged pulse 
of 48 h in both the cellular and the released axonin-1  (Table 
II). The ratio in cellular axonin-1  had assumed equivalence 
by the end of a 48-h pulse period, whereas the ratio in the 
released form had reached a value >10 at this point. Account- 
ing for the fact that the ratios for the released axonin-1  were 
derived from cumulative data obtained over the entire pulse 
period and show a  clearly increasing tendency, the instan- 
taneous ratio in axonin-1  released at 48 h was estimated to 
be considerably higher. Since, under the conditions of this 
experiment, [3H]leucine labeling represents exclusively the 
slow-turnover pool and most of the  [3~S]methionine  is  lo- 
cated in axonin-1 of the fast-turnover pool, these data clearly 
The Journal of Cell Biology, Volume  109, 1989  2372 6 
I"  4 
o  '  ,'o  ' 
Duration Of ohne (h) 
Figure 6. Radioactive pulse-chase experiments reveal two kineti- 
cally distinct forms of axonin-l.  The experimental conditions  for 
these studies were governed to a high degree by the life cycle of the 
DRG cultures used. Dissociated DRG neurons, when grown in the 
presence of 5-fluorodeoxyuridine, developed a dense meshwark of 
axons during the first 6-8 d in culture and thereafter ceased to grow 
and passed into an apparently stationary period lasting for *10 d. 
During this period,  neuronal cell death was found not to exceed 
20%. Thereafter,  however, signs of progressive deterioration  be- 
came evident. To work under the steady-state assumption,  kinetic 
experiments had to be carried out between day 8 and day 18 in cul- 
ture.  Starting at day 5 in culture,  dissociated  DRG neurons were 
pulsed  for 6.5  d  with  0.25  mCi  [3H]leucine per milliliter.  The 
medium was removed and cells were washed and chased.  At each 
of the indicated time points of chase, the cells of three cultures were 
harvested after removal of the medium and axonin-I was isolated 
by immunoprecipitation,  and analyzed by SDS-PAGE and fluorog- 
raphy. Bands corresponding to axonin-I were located in the gel by 
means of fluorography, cut out, and the radioactivity incorporated 
into axonin-I was determined by liquid scintillation counting. Each 
value was determined from triplicate cultures and the vertical bars 
represent  standard deviation. 
identify  the  fast-turnover  pool  as  the  source  of released 
axonin-l. 
The proportion of the fast-turnover pool devoted to release 
was evidenced during the chase of a short duration (11,5 h) 
second pulse of [35S]methionine  (Fig.  7 B).  (After a pulse 
period of 11.5 h, ,x,6% of the slow-turnover pool (h/2 =  104 
h)  is  labeled,  whereas  the  fast-turnover pool has reached 
*75 % of saturation.) The release of [35S]methionine-labeled 
axonin-1  during the [35S]methionine  pulse (63-74.5  h) was 
1,243  cpm,  i.e.,  approximately one-half of the  estimated 
pool size of the fast-turnover pool (a lag period of a few hours 
precedes the period of a linear rate of release).  In the two 
chase periods,  the  [35S]methionine  released with  axonin-1 
was between 70 and  80%  of the  quantity  that had disap- 
peared from the cells: during the first chase of 23 h,  1,360 
cpm of pS]methionine  had disappeared from the cellular 
axonin  (i.e.,  the  fast-turnover pool)  and  1,120  cpm were 
released; during the second chase of 23 h, 260 cpm disap- 
peared  from the  cellular axonin-1  and  190  cpm were  re- 
leased. These data are in good agreement with the 60% of 
the throughput to be attributed to release, as calculated from 
the data obtained during the 48-h [35S]methionine-pulse pe- 
riod of the double-labeling experiment (Fig.  7 A). 
The Slow-Turnover Form Is Exposed at the Cell 
Surface, the Fast-Turnover Form Is Intracellular 
To assess whether there was extracellular exposure of either 
one of the kinetically identifiedforms,-externally accessible 
proteins were covalently labeled by the addition of the amino 
group-reactive agent biotin-X-NHS to live cells, at time 0 h 
and time 64 h of chase after a 4-d pulse of [3H]leucine (Fig. 
8). If biotinylation was carried out immediately at the end 
of the pulse, ~25 % of the labeled axonin-1 was biotinylated. 
After a chase of 64 h, when the fast-turnover form had virtu- 
ally disappeared (cf. Fig. 6), ~45 % of the remaining slow- 
turnover form was biotinylated. The absolute amounts of bi- 
otinylated axonin-1  at time-points 0  h  and 64 h  were very 
similar.  The  complete disappearance  of the  fast-turnover 
form (the white area in the bar representing total axonin-1) 
between 0 h and 64 h of chase was not accompanied by a cor- 
responding reduction in biotinylated axonin-1; the slight de- 
crease of biotinylated axonin-1  at the later time-point fol- 
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Figure 7. Released axonin-1 is derived from the fast-turnover pool; 
the secretory pathway does not include the slow-turnover pool. (A) 
After a pulse with 0.25 mCi [3H]leucine per milliliter for 4 d and 
a chase of 63 h, DRG neurons were subjected to a second pulse with 
[3~S]methionine (0.25 mCi/ml) for 48 h. (D; t~H]~) [35H]leucine in 
cellular  axnnin-1; (m; [3HI,) [3H]leucine in supernatant  axonin-1; 
(zx; FsS]c) [35S]methionine in  cellular  axonin-1; and  (A;  ['Sis) 
[3~S]methionine in supernatant axonin-l.  The arrow at 63 h indi- 
eates the beginning of the [35S]methionine pulse. (B) Same condi- 
tion as A, except that the second pulse with [35S]methionine was 
for 11.5 h, followed by two chase periods of 23 h. At the end of the 
[35S]methionine pulse  and  after each chase  period,  the  culture 
medium of all cultures was harvested,  the cells were washed, and 
fresh medium was added. The arrow at 63 h indicates the beginning 
of the [3SS]methionine pulse; arrows at 74.5 h and 97.5 h indicate 
the beginning of the consecutive chase periods,  respectively. ([]) 
[3H]leucine in cellular  axonin-l;  (zx) [~sS]methinnine in cellular 
axonin-1; (A) [35Slrnethionine in supernatant axonin-1. The values 
indicated are the mean of triplicate measurements; the vertical bars 
represent standard deviation.  The curve for the released axonin-I 
during the first chase period (B) has been arbitrarily drawn for the 
sake of clarity. The initial slope has been taken from the slope of 
the release found at this time in the long time pulse of [35S]methio- 
nine (,4). 
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Slow-Turnover Form in Cellular and Released Axonin-1 
Ratio 
([35Slmethionine/[3H]leueine) 
Time  Cellular axonin-  1  Supernatant  axonin-  1 
mean 5: SEM  mean 5: SEM 
Pulse with [35S]methionine 
3.5 h  0.38  +  0.04  2.2 +  0.1 
6 h  0.44 +  0.02  3.2  +  0.1 
11.5 h  0.81  -1- 0.02  4.5  +  0.2 
48 h  1.01 5:0.07  10.8 5:0.4 
Chase after  11.5-h pulse of 
[35Slmethionine 
23 h  0.26  +  0.02  4,6 5- 0.4 
47 h  0.17  +  0.01  1.1  5- 0.1 
DRG neurons were pulsed for 4 d with [3H]leucine. After a chase period of 
63 h, cells were pulsed with [35S]methionine for the time period indicated. 
The sapernatant and cells were harvested separately and axonin-1 was isolated 
by  immunoprecipitation, followed by SDS-PAGE/fluorography. The  cor- 
responding bands were cut out of the gels and the ratio of [3SS]methio- 
nine/[3H]leucine was determined by liquid scintillation counting. 
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Figure 8.  The  slow-turnover 
form of axonin-1  is modified 
by externally  added biotin-X- 
NHS, i.e., it is membrane sur- 
face  exposed;  the  fast-turn- 
over  form is  protected  from 
external  biotinylation,  and  is 
therefore  presumed to be in- 
tracellular.  Cultures  of  dis- 
sociated  DRG  neurons  were 
subjected to an extended pulse 
with 0.2 mCi [3H]leucine per 
milliliter  (4  d),  the  superna- 
tant was removed and the cells 
were chased.  At the beginning 
of the chase period and after 
64  h,  externally  accessible 
proteins  of the live cells were 
modified by reaction with bio- 
tin-X-NHS.  Biotinylated  and 
nonbiotinylated  proteins  were 
separated  by chromatography 
on  Streptavidin-agarose.  Ax- 
onin-I  of both  fractions  was 
immunoprecipitated  and  subjected  to  SDS-PAGE/fluorography. 
The bands corresponding to axonin-I  were located  in the gels by 
means of the tluorographic replica and cut out of the gels. The con- 
tent of [3H]leucine in axonin-1 was determined by liquid  scintilla- 
tion counting.  The first bar at each time point represents  the total 
radioactivity  of cellular axonin-1. As a visual  aid, the proportion 
of slow-turnover axonin-1 at both time points,  as calculated  based 
on pool sizes and turnover rates, is represented  by the hatched area 
of the bar.  The solid bar represents  the radioactivity of axonin-I 
modified by external biotinylation  and affinity purified by consecu- 
tive  subjection  to Streptavidin-agarose  and immunoprecipitation. 
All experiments were carried out in triplicate;  the vertical lines rep- 
resent SEM. As a control for the restriction  of the labeling to exter- 
nally exposed proteins, cytosolic aspartate aminotransferase,  an en- 
zyme of established  cytosolic location (Behra  et al.,  1982),  was 
included  into the study. After exposure  of cultured  DRG neurons 
to external biotin-X-NHS,  cytosolic aspartate aminotransferase  was 
found to be free of biotin,  thus confirming intracellular  proteins to 
be protected  from labeling. 
lowed the rate of disappearance  of the slow-turnover form 
during this lapse of time. The fact that only ~45% ofaxonin- 
1 was biotinylated after 64 h of chase, when only the slow- 
turnover pool was radioactive, most likely is a matter of yield 
rather  than  evidence for two populations  of slow-turnover 
axonin-1. An overall yield of 45 % appears reasonable for a 
procedure comprising a chemical modification of live cells 
in culture and two  steps  of affinity chromatographic puri- 
fication.  The aforementioned data clearly demonstrate that 
at least a substantial proportion of the slow-turnover form is 
exposed to the cell surface. The fact that the quantity of bio- 
tinylated axonin-1 was not higher at time 0 h of chase, when 
approximately equal quantities of both pools were present, 
indicates the fast-turnover form to be protected from biotiny- 
lation,  and hence to be intracellular. 
Axonin-1 Released  from the Fast-Turnover  Pool Is Not 
Exposed on the Cell Surface before Release 
The origin (cell surface vs. intracellular) of released axonin-1 
was more directly  investigated by external  biotinylation of 
live cells  after the  second pulse  in a  pulse-chase double- 
labeling  experiment.  As  shown  in  Table  III, the  released 
axonin-1  rapidly  acquired  [35S]methionine  (the  second la- 
bel)  which became prevalent  over  [3H]leucine in <4 h  of 
pulse,  as concluded from the ratio of [35S]methionine/[3H]  - 
leucine. The biotinylated, thus externally accessible, cellular 
axonin-1  showed delayed accumulation of [35S]methionine, 
the isotope ratio remaining strongly in favor of [3H]leucine, 
even after a  10-h pulse.  In view of these data,  the biotin- 
ylated, i.e., the cell surface exposed form of axonin-1, cannot 
be the source of released  axonin-1. 
Considering  that  the  measured  [3sS]methionine/[3H]leu- 
cine ratios of released axonin-1 are derived from cumulative 
values obtained over the respective times of secretion,  and 
knowing  that  the  released  form is  derived  from the  fast- 
turnover pool, which in this labeling situation contains only 
[35S]methionine,  the actual  ratios  of the cellular precursor 
pool of released axonin-1  at each time point is expected to 
be even higher, approaching the value of its precursor pool 
after a  prolonged time,  when the initial  lag and saturation 
period  becomes negligible.  This  prediction  is  fulfilled,  if 
homogeneity of the slow-turnover pool with respect to cell 
surface exposure is assumed and the data of external biotiny- 
lation are corrected for incomplete reaction efficiency. In this 
case (Table UI, last column), the ratio of the released mate- 
rial is indeed below the corresponding ratio of the biotin-free 
axonin-1 at all time points, reaching a value close to half of 
the ratio of the intracellular (biotinylation protected) pool af- 
ter 10 h of pulse, when the labeling of the fast-turnover pool 
turns  towards  saturation.  These data indicate  a  precursor- 
product relationship between the internal, fast-turnover pool 
and the released  axonin-1. 
Soluble Axonin4 Is Quantitatively the Major Form 
In embryonic chicken brair~ membranes,  axonin-1 had been 
found  substantially  less  abundant  than  Ng-CAM (Fig.  4). 
Among the soluble proteins of the embryonic vitreous fluid, 
however, axonin-1 had outranked Ng-CAM by at least one or- 
der  of magnitude.  This  observation  suggested  the  major 
proportion of axonin-1 to be in solution and only a relatively 
small fraction to occur in membrane-bound form. To obtain 
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Dissociated Cultures 
Duration of 
[35S]methionine  Form of  [35S]  Methionine/[3H]leucine 
pulse  axonin-  1  [35S]Methionine/[3Hlleucine  corrected 
h  mean  -I-  SEM 
1  Cellular,  biotin-  0.47  5:0.02 
biotin  +  0.02  5:0.002 
Supernatant  0 
4  Cellular,  biotin- 
biotin  + 
Supernatant 
10  Cellular,  biotin- 
biotin  + 
Supernatant 
2.1 
0.02 
0 
1.2  5:0.1  3.2 
0.38  5:0.02  0.38 
1.3  5:0.1  1.3 
1.9  +  0.3  8.9 
0.7  +  0.1  0.7 
4.2  5:0.3  4.2 
DRG neurons were pulsed for 4 d with 0.25 mCi [3H]leucine per milliliter.  After a chase for 63 h, [3SS]methionine (0.2 mCi/ml) was added for the time periods 
indicated. After collecting the supernatant, externally accessible proteins of the live cells were modified by reaction with biotin-X-NHS for 2 rain. Subsequently, 
the cells were washed and lysed. The cellular proteins were subdivided into a biotinylated (i.e., extracellularly exposed) and a nonbiotinylated (i.e., intracellular) 
fraction by affinity chromatography on Streptavidin-agarose. From both fractions, axonin-I was isolated by immunoprecipitation, followed by SDS-PAGE/fluorog- 
raphy. Corresponding bands were cut out of the gels, rehydrated, and the [3~S]methionine/[3H]leucine  ratio was determined by liquid scintillation counting. In 
the last column, nonbiotinylated fractions were corrected for the efficiency  of this modification-reaction (yield  53%). 
a  quantitative  estimation  on  the  ratio  of  soluble  and 
membrane-bound axonin-1, the vitreous fluid and the retina 
of 14-d chicken embryos were investigated for their content 
in axonin-1.  Using ELISA, ',~50 ng of axonin-1  were found 
in  the  retina,  whereas  between  1.2  and 2  #g  of soluble 
axonin-1 were present in the vitreous fluid. As a conservative 
estimate, assuming a constant rate of accumulation between 
embryonic day 6 and 14 and the absence of degradation, the 
daily secretion of axonin-1  into the vitreous cavity corre- 
sponds to approximately five times the amount of the axonin- 
1 present in the retinal tissue, the estimated throughput of the 
secretory pool in the retina being at least three times higher 
than in the in vitro experiments with embryonic DRG neu- 
rons. These in vivo data confirm the evidence obtained from 
previous in vitro studies (Stoeckli et al., 1989; Ruegg et at., 
1989;  this paper) that the soluble form of the extracellular 
space is quantitatively predominant and that only a minor 
proportion of axonin-1  is found in cell association. Such a 
quantitative predominance of the soluble over the membrane- 
associated form in both total quantity and rate of production 
is unprecedented for cell adhesion molecules reported to 
date. 
Discussion 
Membrane-associated Axonin-1, by Operational and 
Structural Criteria, Is a Cell Adhesion Molecule 
A membrane-associated homologue of the axonally secreted 
protein axonin-1 has been identified. By its predominant lo- 
cation in nerve fiber tracts, axonin-1 appears closely related 
to the neural cell adhesion proteins of the L1/nerve growth 
factor-inducible  large  external  glycoprotein  (NILE)/Ng- 
CAM/G4/8D9-group, Fll, and neurofascin, which, because 
of their common topographic restriction in their expression 
pattern, recently have been gathered under the denomination 
AxCAM (Rutishauser and Jessel, 1988). In its occurrence in 
nerve fiber tracts, axonin-1  overlaps with N-CAM,  which 
however, is found in many other areas of the nervous system 
too (Daniloff et al.,  1986).  Addition of anti-axonin-1 Fab 
fragments to cultured dorsal root ganglia during the time of 
axon growth resulted in alterations in the fasciculation pat- 
tern,  which  closely  corresponded  to  those  evoked  with 
anti-N-CAM Fab fragments (Rutishauser et al.,  1978) and 
have recently been observed in the presence of antibodies to 
a number of AxCAMs, namely NILE (StaUcup and Beasley, 
1985),  L1 (Fischer et al.,  1986),  Ng-CAM (Friedlander et 
al., 1986), G4 and Fll (Rathjen et at., 1987a), and neurofas- 
cin (Rathjen et at., 1987b). All AxCAMs, as well as N-CAM, 
have been reported to be membrane proteins, which exert 
their adhesive function by the binding of their surface-ex- 
posed portion to appropriate ligands of adjacent cell mem- 
branes. In accordance with this concept, anti-axonin-1 Fab 
fragments were indeed located at the axonal surface at the 
end of the fasciculation perturbation experiment, implying 
axonin-I  contributions to fasciculation in a  membrane-as- 
sociated state. By the facts that it is situated in axonal mem- 
branes, exposed to the axonal surface, and its specific anti- 
bodies  perturb  fasciculation,  membrane-bound  axonin-1 
fulfills the operational definition of a cell adhesion molecule 
(Frazier and Glaser,  1979;  Rutishauser and Jessel,  1988). 
Besides meeting operational criteria for a  cell adhesion 
molecule, axonin-1 also expresses the L2/HNK-1 and the L3 
epitope carbohydrate structures shared by a number of Ax- 
CAMs  and  other  Ca2+-independent  adhesion  molecules 
(Schachner, 1989).  The underlying carbohydrate structures 
have been proposed to represent family traits of adhesive 
molecules (Kruse et al., 1984; Kiicherer et al., 1987),  and, 
recently, evidence for their direct participation as ligands in 
the adhesive interaction has been presented (Kiinemund et 
al.,  1988;  Schachner,  1989).  These structural features, in 
conjunction with its topographical location and its opera- 
tional qualification as a cell adhesion molecule, justifies a 
bona fide assignment of axonin-1,  in its membrane-bound 
form, to the AxCAMs. 
The nature of the membrane association of axonin-1  was 
investigated by membrane subfractionation studies. Prepara- 
tions  of embryonic  brain  membranes  were  subjected  to 
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ble proteins (ultmsonication), removal of peripheral mem- 
brane proteins (high salt and high pH), and the solubilization 
of integral membrane proteins (CHAPS). A minor propor- 
tion of axonin-1 was found in a vesicle-enclosed form, possi- 
bly representing the content of secretory vesicles that had 
copurified  with  the  plasma  membranes.  The  peripheral 
membrane proteins were solubilized in two fractions by con- 
secutive application of two release procedures of different 
harshness, to estimate the relative strength of membrane at- 
tachment of axonin-1. Exposure to high salt, a relatively mild 
extraction procedure, was followed by the markedly harsher 
exposure to high pH  (Steck and Yu,  1973;  Fujiki et al., 
1982).  In  combination,  these  procedures  removed about 
one-third (37 %) of axonin-1 from the sonicated membranes. 
The remaining axonin-1 was found releasable by subsequent 
exposure to CHAPS, and hence operationally qualified as an 
integral membrane protein. The data on absolute and specific 
contents of axonin-1  in  the brain  membrane subfractions 
reflected a discontinuity in the strength of membrane associ- 
ation. (a) The specific concentration of axonin-1 in the pro- 
teins solubilized by the relatively mild high-salt procedure 
was more than twofold higher than in the material removed 
by the clearly harsher high pH condition, a fact which indi- 
cates this form of axonin-1 to be among the peripheral mem- 
brane proteins with a relatively weak membrane attachment. 
(b) Among the proteins resistant to high pH release and only 
extractable by CHAPS, the specific concentration of axo- 
nin-1 was >12-fold higher than among the high pH-released 
proteins, indicating this form to be among the most tightly 
bound membrane proteins. Therefore, with respect to the rel- 
ative strength of membrane attachment, a very weakly bound 
peripheral  membrane form of axonin-1  is clearly distinct 
from an integral membrane form with a very strong mem- 
brane association. 
The integral membrane form of axonin-1  was compared 
with the soluble form by physicochemical, immunological, 
and protein-chemical criteria. The fact that the soluble and 
the integral membrane forms of axonin-1  are identical with 
respect to their isoelectric variant patterns, show complete 
fusion of their precipitin lines in the Ouchterlony double- 
diffusion test, and generate highly similar peptide patterns 
upon partial proteolytic cleavage, indicate a very high degree 
of structural similarity. However, a distinct difference in the 
relative migratory distance was observed  on SDS-PAGE. 
The membrane-associated form characterized as an integral 
membrane  protein  displayed a  lower  apparent  molecular 
mass than its soluble counterpart. The identity of the anti- 
genic determinants and the identity of all but one out of 26 
proteolytic peptides, suggests that the difference in the elec- 
trophoretic migration rate may result from a localized struc- 
tural difference of two otherwise identical proteins. A differ- 
ence in the length of the polypeptide chain at either end of 
the molecule is a conceivable explanation but also a local 
difference arising from posttranslational modification may 
be considered. The molecular mass difference was main- 
tained after enzymatic removal of N-linked glycans, indi- 
cating the underlying structural difference not to reside in 
N-linked carbohydrate. The qualification of a protein as an 
integral membrane protein based on resistance to solubiliza- 
tion by high salt or high pH is operational and hence, no con- 
clusions on the nature of  the membrane attachment are possi- 
ble. The apparent molecular mass of the membrane-bound 
form being smaller than that of soluble axonin-1, membrane 
anchorage by covalently attached lipid is conceivable (Fergu- 
son and Williams, 1988). 
The Soluble Form of  Axonin-1 Is Not Derived from 
the Membrane Form, but Directly Secreted  from an 
lntraceUular Pool; As a Soluble Molecule Interacting 
with Adhesion Receptors, It Might Modulate 
Adhesive Interactions 
Cell adhesion molecules, by definition, are considered to ex- 
ert their function in membrane-association, however, a pos- 
sible role in solution has been suggested by the observation 
of soluble forms of N-CAM (Thiery et al., 1977; Goridis et 
al.,  1978; Rohrer and Schachner, 1980)  and NILE (Salton 
et al.,  1983;  Stallcup et al.,  1983;  Sweadner,  1983) in the 
conditioned media of  neuronal cultures. The release of NILE 
(which is the rat homologue to L1, Ng-CAM, G4, and 8D9; 
Rutishauser and Jessel,  1988)  and of another cell surface 
glycoprotein, possibly corresponding to N-CAM, was found 
to be evoked or enhanced by conditions which favor transmit- 
ter secretion and the mechanism of release was investigated 
(Sweadner,  1983).  Shedding from the cell  surface rather 
than classical secretion was found to underly this protein re- 
lease, as evidenced by the fact that the released form was 
found  to  be  derived  from  a  higher  molecular  weight, 
membrane-bound, and surface exposed precursor (Swead- 
net, 1983).  Soluble axonin-1,  in contrast, is not exposed to 
the cell surface before its release, but directly originates from 
an intracellular pool.  This observation speaks in favor of 
classical secretion after packaging into secretory vesicles as 
the mechanism of release. 
Dualistic  expression  of a  protein  in  a  secreted  and  a 
membrane-bound form has previously been observed, e.g., 
with immunoglobulins (Cushley et al.,  1982)  and muscle 
acetylcholinesterase (Rotundo and Fambrough,  1980).  Se- 
creted acetylcholinesterase, in accordance with our present 
findings on secreted axonin-l, was also derived from a rap- 
idly turning-over,  intracellular  pool,  and,  as  membrane- 
bound axonin-1, the membrane-inserted form of the esterase 
had a markedly longer half-life (Rotundo and Fambrough, 
1980). Whether both secreted and membrane-bound axonin- 
1 are  expressed by the  same cell at the  same time,  and 
whether there is independent regulation of their expression, 
remains to be determined. 
Secreted axonin-1 occurs in relatively high concentrations 
in embryonic cerebrospinal fluid and vitreous fluid (Ruegg 
et al.,  1989) and, with respect to the overall abundance in 
the central nervous system, is clearly the prevalent form. 
This is in notable contrast to the distribution of the other cell 
adhesion molecules that were investigated in this respect, 
namely N-CAM or Ng-CAM, where the major proportion 
is membrane associated and only trace amounts can be de- 
tected in solution (Fig. 4, A-C). Although a functional role 
of secreted axonin-I has not been determined thus far, the 
molecule carries  features that suggest it to have adhesive 
properties. (a) Secreted axonin-I is structurally very similar 
to its membrane-bound homologue, which is  involved in 
neurite fasciculation.  (b)  The  antibodies evoking the  ob- 
served alterations in  the  fasciculation pattern,  have been 
raised against the soluble antigen. Hence, the structure un- 
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pressed on both forms. (c) As its membrane-bound homo- 
logue, secreted axonin-1  carries both the L2/HNK-1 and the 
L3 epitopes. 
The possibility of  cell adhesive properties on a soluble gly- 
coprotein  secreted  from  axons  during  neurogenesis  en- 
courages speculation about its functional role. Depending on 
its  molecular configuration,  a  soluble  adhesion molecule 
may have inverse functions. By binding in a soluble monova- 
lent form to a cell surface or ECM receptor, it could effect 
inhibition of cell adhesion, whereas in a bivalent form, it 
could act as a cross-linker between membranes or between 
membranes and the ECM, hence promoting cell adhesion. 
In the light of these suppositions, the membrane surface-ad- 
sorbed form of axonin-1  (released by high salt and high pH) 
could be  interpreted to  represent  receptor-bound soluble 
axonin-1.  The adventitious trapping of soluble axonin-1 from 
the  extracellular  fluid  during  the  membrane  preparation 
process cannot be excluded on the basis  of the currently 
available data, and therefore, unequivocal identification and 
localization of in vivo membrane  surface-bound secreted 
axonin-1 by immunohistocbemical staining in tissue sections 
is necessary. Yet, as a working hypothesis, it seems reason- 
able to assume that the intense staining  along nerve fiber 
tracts reflects the integral membrane form, because this form 
represents the quantitatively major form of axonin-1 found 
in membranes. Since virtually all reported observations lo- 
cate the site of axonal protein secretion to the axon tip (Kelly, 
1988), the peripherally adsorbed form of membrane-associ- 
ated axonin-1 may occur in areas of high growth cone densi- 
ties. Appropriate binding sites provided, high local concen- 
trations in the narrow extracellular space in proximity of the 
site of release would favor preferential binding to cell sur- 
faces and/or ECM. Staining of the inner plexiform layer of 
the retina (Fig.  1 C) with its high density of growth cones 
at this stage of  development represents an intriguing observa- 
tion in this context, as it could reflect secreted axonin-1. Both 
ultrastructural localization of the site of axonin-1  secretion 
from growth cones of elongating axons and its extracellular 
location will be necessary to test this hypothesis. Further 
studies will also include investigations on the ligand function 
of axonin-1 and its role in neural development. Preparative 
efforts to produce sufficient quantities of pure axonin-1 for 
studies towards this goal, are currently in progress in our lab- 
oratory. 
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